(Q30898904)

27 June 2017

1 reference

title

Treatment of osteoporosis with calcium and vitamin D. Systematic review (English)

1 reference

27 June 2017

0 references

0 references

Vallecillo G

1

1 reference

27 June 2017

Díez A

series ordinal

2

1 reference

27 June 2017

Carbonell J

series ordinal

3

1 reference

27 June 2017

González Macías J

series ordinal

4

1 reference

27 June 2017

publication date

1 June 2000

1 reference

27 June 2017

1 reference

27 June 2017

volume

115

1 reference

27 June 2017

issue

2

1 reference

27 June 2017

page(s)

46-51

1 reference

Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

The diagnosis of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Nutritional factors in osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

The role of the vitamin D endocrine system in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Calcium supplementation and bone loss in middle-aged women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

The effects of calcium supplementation and exercise on bone density in elderly Chinese women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

A 4-year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Calcitriol in the treatment of postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Calcitriol treatment is not effective in postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Treatment of postmenopausal osteoporosis with calcitriol or calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971461-8

10.1016/S0025-7753(00)71461-8

7 January 2021

Identifiers

DOI

1 reference

27 June 2017

1 reference